PharmaResearch Co., Ltd.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
14,500 KRW
92.04 B KRW
350.12 B KRW
5.58 M
About PharmaResearch Co., Ltd.
Sector
Industry
CEO
Ji-Hoon Sohn
Website
Headquarters
Gangneung-si
Founded
2001
IPO date
Jul 24, 2015
IPO offer price
48.14 USD
Identifiers
2
ISINKR7214450009
PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine biotechnology. It offers products which fall under the categories of quality of life and tissue regeneration. It also engages in the manufacture of medical equipment. The company was founded on March 3, 2001 and is headquartered in Gangneung-si, South Korea.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 214450 is 381,500 KRW — it has increased by 3.22% in the past 24 hours. Watch PharmaResearch Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange PharmaResearch Co., Ltd. stocks are traded under the ticker 214450.
214450 stock has fallen by −1.53% compared to the previous week, the month change is a −15.48% fall, over the last year PharmaResearch Co., Ltd. has showed a 55.08% increase.
We've gathered analysts' opinions on PharmaResearch Co., Ltd. future price: according to them, 214450 price has a max estimate of 840,000.00 KRW and a min estimate of 640,000.00 KRW. Watch 214450 chart and read a more detailed PharmaResearch Co., Ltd. stock forecast: see what analysts think of PharmaResearch Co., Ltd. and suggest that you do with its stocks.
214450 reached its all-time high on Aug 26, 2025 with the price of 713,000 KRW, and its all-time low was 29,500 KRW and was reached on Mar 23, 2020. View more price dynamics on 214450 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
214450 stock is 6.21% volatile and has beta coefficient of −0.01. Track PharmaResearch Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is PharmaResearch Co., Ltd. there?
Today PharmaResearch Co., Ltd. has the market capitalization of 3.88 T, it has decreased by −2.46% over the last week.
Yes, you can track PharmaResearch Co., Ltd. financials in yearly and quarterly reports right on TradingView.
PharmaResearch Co., Ltd. is going to release the next earnings report on Mar 13, 2026. Keep track of upcoming events with our Earnings Calendar.
PharmaResearch Co., Ltd. revenue for the last quarter amounts to 135.40 B KRW, despite the estimated figure of 138.53 B KRW. In the next quarter, revenue is expected to reach 154.30 B KRW.
214450 net income for the last quarter is 48.97 B KRW, while the quarter before that showed 47.40 B KRW of net income which accounts for 3.31% change. Track more PharmaResearch Co., Ltd. financial stats to get the full picture.
Yes, 214450 dividends are paid annually. The last dividend per share was 1.10 K KRW. As of today, Dividend Yield (TTM)% is 0.29%. Tracking PharmaResearch Co., Ltd. dividends might help you take more informed decisions.
PharmaResearch Co., Ltd. dividend yield was 0.42% in 2024, and payout ratio reached 12.30%. The year before the numbers were 0.87% and 12.55% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 19, 2025, the company has 436 employees. See our rating of the largest employees — is PharmaResearch Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PharmaResearch Co., Ltd. EBITDA is 211.90 B KRW, and current EBITDA margin is 39.90%. See more stats in PharmaResearch Co., Ltd. financial statements.
Like other stocks, 214450 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PharmaResearch Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PharmaResearch Co., Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PharmaResearch Co., Ltd. stock shows the buy signal. See more of PharmaResearch Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.